Lyrica®
Lyrica® is a pharmaceutical drug with 10 clinical trials. Historical success rate of 87.5%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.8%
7 of 9 finished
22.2%
2 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
Pre vs Post Block in Total Knee Arthroplasty (TKA)
Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study
A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin
PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers
Clinical Trials (10)
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
Pre vs Post Block in Total Knee Arthroplasty (TKA)
Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study
A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin
PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers
Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain
Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects
Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica
Study of Pregabalin in the Prevention of Central Neuropathic Pain in Acute Spinal Cord Injury
Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10